Prevalence
Clinical
features
Differential
Diagnosis
Investigations
Therapy
Prevention
Prognosis
|  |  | | Therapy |
Give patients with distal ulcerative colitis rectal
a
and oral 5-aminosalicylate
a
Why?
-
Rectal aminosalicylates lead to more remission than low-dose rectal steroids or rectal
budesonide, but are not clearly better than high-dose rectal steroids
a
-
Combining rectal and oral aminosalicylates stops rectal bleeding in more patients and sooner (on average by 13 days) than either alone
a
Ulcerative colitis: combining oral and rectal mesalamine stops rectal bleeding better than either alone
| Patient |
Treatment |
Comparison |
Outcome |
CER |
RRR (95% CI) |
NNT
(95% CI) |
distal ulcerative colitis
a
|
daily oral mesalamine and twice weekly rectal mesalamine
|
oral or rectal mesalamine
|
cessation of rectal bleeding
at
6
weeks
|
60%
|
40%
(1% to
96%)
|
4
(2 to
88)
|
Ulcerative colitis: rectal 5-ASA is more effective than low-dose rectal steroids at inducing remission
| Patient |
Treatment |
Comparison |
Outcome |
CER |
OR (95% CI) |
NNT
(95% CI) |
distal ulcerative colitis
a
|
low-dose rectal corticosteroids
|
rectal 5-ASA
|
symptomatic remission
at
2-7
weeks
|
9%
|
2.42 (1.72 to
3.41) |
-10
(-18 to
-6)
|
|
|
rectal 5-ASA
|
budesonide
|
symptomatic remission
at
4
weeks
|
9%
|
0.41 (0.18 to
0.94) |
20
(14 to
200)
|
|